Delivery Order SPE2DB22D2009-SPE2DB25FM0UN
Award Date 8/8/25
Potential Completion Date 8/11/25
Potential Value $5.2K
Federal Agency
Awardee
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $8,202.22 to AmerisourceBergen Drug Corp for the supply of DUPIXENT 300 MG/2 ML PEN 2ML on August 4, 2025, with an ultimate completion date of August 5, 2025. This competitively awarded, firm fixed-price delivery order carries no set-aside designation and represents a small-value transaction within AmerisourceBergen's broader pharmaceutical supply portfolio to federal customers. The place of performance is located in...
- The U.S. Defense Logistics Agency (DLA) awarded a $58,180.33 Firm Fixed Price delivery order contract to AmerisourceBergen Drug Corp's Corporate Office division. The contract is for the supply of 4565964265 DUPIXENT 300 MG/2 ML PEN 2ML, a prescription pharmaceutical product, with an ultimate completion date of September 30, 2024. This delivery order is part of a larger Indefinite Delivery Contract (IDC) valued at up to $999,999,999 through December 2025 that AmerisourceBergen holds with the...
- AmerisourceBergen Drug Corp was awarded a delivery order on September 3, 2025, by the Defense Logistics Agency (DLA) for DUPIXENT 300 mg/2 ml pen injectors valued at $10,570.09 under a firm fixed-price contract. The order is set to be completed by September 4, 2025, with performance conducted at the company's corporate office location in Conshohocken, Pennsylvania. This competitively awarded delivery order represents a single pharmaceutical supply transaction within DLA's medical procurement...
- The Defense Logistics Agency awarded a $5,001.99 firm fixed-price delivery order to AmerisourceBergen Drug Corp for DUPIXENT 300 mg/2 mL pens on July 18, 2025, with an ultimate completion date of July 21, 2025. This non-set-aside contract represents a delivery order issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00 and running through December 2026. The pharmaceutical product will be delivered to...
- The U.S. Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract worth $4,059.09 to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation, for the supply of 4563942820 DUPIXENT 300 MG/2 ML PEN 2ML pharmaceutical products. This delivery order is part of a larger indefinite delivery contract (IDC) awarded to AmerisourceBergen Drug Corp by DLA, with a potential value of $999,999,999.00 and a performance period through December 31, 2025. The IDC...
- The U.S. Defense Logistics Agency (DLA) has awarded a firm fixed price delivery order to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to provide DUPIXENT 300 MG/2 ML PEN 2ML pharmaceuticals. The award, valued at $5,921.36, has a completion date of February 28, 2024. Amerisourcebergen Drug Corp is the prime contractor on this order, which is not associated with any set-aside program. This delivery order is issued under a larger indefinite delivery contract (IDC)...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $5,706.66 to AmerisourceBergen Drug Corp for the supply of DUPIXENT 300 MG/2 ML PEN 2ML, with an ultimate completion date of September 9, 2025. This firm fixed-price, competitively awarded contract contains no set-aside designation and represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999.999 billion through December 2026. The place of...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $8,747.93 to AmerisourceBergen Drug Corp for the supply of DUPIXENT 300 mg/2 mL pen injectors. The contract is a firm fixed-price delivery order with an ultimate completion date of September 3, 2025, and represents a non-set-aside competitive award. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, will perform at its corporate office location. This delivery order falls under the company's broader...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for DUPIXENT 300 mg/2 ml pen injectors, valued at $6,777.99, with an ultimate completion date of August 15, 2025. This competitively awarded, firm fixed-price delivery order carries no set-aside designation and represents a continuation of the company's ongoing pharmaceutical supply relationship with the federal government. The place of performance is AmerisourceBergen's corporate headquarters in Conshohocken,...
- The Defense Logistics Agency (DLA) awarded a $11,458.33 delivery order to AmerisourceBergen Drug Corp for Dupixent 300 mg/2 mL pen injectors on June 13, 2025, with an ultimate completion date of June 16, 2025. This competitively awarded, firm fixed-price contract represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026. The pharmaceutical distributor...